Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

DIGITAL CONTENT

2 NEWS #PharmaBuzz

media
2 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 860642-69-9, Vpd-737, Serlopitant [usan], Mk-0594, Chembl447955, 3-((3ar,4r,5s,7as)-5-((r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-4-(4-fluorophenyl)hexahydro-1h-isoindol-2(3h)-yl)cyclopent-2-enone

Molecular Formula

C₂₉H₂₈F₇NO₂

Molecular Weight

555.5 g/mol

InChI Key

FLNYCRJBCNNHRH-OIYLJQICSA-N

FDA UNII

277V92K32B

Serlopitant has been investigated for the treatment of Prurigo Nodularis.

1 2D Structure

Serlopitant

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

3-[(3aR,4R,5S,7aS)-5-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-4-(4-fluorophenyl)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]cyclopent-2-en-1-one

2.1.2 InChI

InChI=1S/C29H28F7NO2/c1-16(19-10-20(28(31,32)33)12-21(11-19)29(34,35)36)39-26-9-4-18-14-37(23-7-8-24(38)13-23)15-25(18)27(26)17-2-5-22(30)6-3-17/h2-3,5-6,10-13,16,18,25-27H,4,7-9,14-15H2,1H3/t16-,18-,25-,26+,27+/m1/s1

2.1.3 InChI Key

FLNYCRJBCNNHRH-OIYLJQICSA-N

2.1.4 Canonical SMILES

CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2CCC3CN(CC3C2C4=CC=C(C=C4)F)C5=CC(=O)CC5

2.1.5 Isomeric SMILES

C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@H]2CC[C@@H]3CN(C[C@H]3[C@@H]2C4=CC=C(C=C4)F)C5=CC(=O)CC5

2.2 Other Identifiers

2.2.1 UNII

277V92K32B

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. 860642-69-9

2. Vpd-737

3. Serlopitant [usan]

4. Mk-0594

5. Chembl447955

6. 3-((3ar,4r,5s,7as)-5-((r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-4-(4-fluorophenyl)hexahydro-1h-isoindol-2(3h)-yl)cyclopent-2-enone

7. Serlopitant (usan)

8. 277v92k32b

9. 3-((3ar,4r,5s,7as)-5-((1r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-4-(4 Fluorophenyl)octahydro-2h-isoindol-2-yl)cyclopent-2-en-1-one

10. 3-[(3ar,4r,5s,7as)-5-[(1r)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-4-(4-fluorophenyl)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]cyclopent-2-en-1-one

11. Serlopitant [usan:inn]

12. Unii-277v92k32b

13. Vpd 737

14. Serlopitant [inn]

15. Serlopitant [who-dd]

16. Gtpl9280

17. Schembl3183159

18. C29h28f7no2

19. Dtxsid701006599

20. Bdbm50277511

21. Mfcd18782619

22. Compound 17 (jiang Et Al. 2009)

23. Db12973

24. Vpd-737; Mk-0594

25. Hy-12114

26. Cs-0003087

27. D09378

28. Q21098912

29. 2-cyclopenten-1-one, 3-((3ar,4r,5s,7as)-5-((1r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-4-(4-fluorophenyl)octahydro-2h-isoindol-2-yl)-

30. 3-((3ar,4r,5s,7as)-5-((r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-4-(4-fluorophenyl)octahydro-2h-isoindol-2-yl)cyclopent-2-en-1-one

31. 3-[(3ar,4r,5s,7as)-5-{(1r)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-4-(4-fluorophenyl)-octahydro-2h-isoindol-2-yl]cyclopent-2-en-1-one

32. 3-[(3ar,4r,5s,7as)-5-{(1r)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-4-(4-fluorophenyl)octahydro-1h-isoindol-2-yl]cyclopent-2-en-1-one

33. 3-[5-{1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-4-(4-fluorophenyl)octahydro-2h-isoindol-2-yl]cyclopent-2-en-1-one

2.4 Create Date

2008-01-28

3 Chemical and Physical Properties

Molecular Formula	C₂₉H₂₈F₇NO₂
Molecular Weight	555.5 g/mol
XLogP3	6.6
Hydrogen Bond Donor Count	0
Hydrogen Bond Acceptor Count	10
Rotatable Bond Count	5
Exact Mass	555.20082627 g/mol
Monoisotopic Mass	555.20082627 g/mol
Topological Polar Surface Area	29.5 Å²
Heavy Atom Count	39
Formal Charge	0
Complexity	888
Isotope Atom Count	0
Defined Atom Stereocenter Count	5
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Indication

Treatment of prurigo nodularis

5 Pharmacology and Biochemistry

5.1 MeSH Pharmacological Classification

Neurokinin-1 Receptor Antagonists

Compounds that inhibit or block the activity of NEUROKININ-1 RECEPTORS. (See all compounds classified as Neurokinin-1 Receptor Antagonists.)

Drugs in Development

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

INTERMEDIATES SUPPLIERS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

ABOUT THIS PAGE

Find Serlopitant manufacturers, exporters & distributors on PharmaCompass

Serlopitant

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

DEVELOPMENTS

2 Drugs in Development

INTERMEDIATES

1 Intermediates Suppliers

DIGITAL CONTENT

2 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

1INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

2DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

What are you looking for?